Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Financing co-led by a leading life science investor and 5AM Ventures expected to fully fund obesity Phase 2 trial assessing nimacimab, Skye's diff...
San Diego, California--(Newsfile Corp. - January 29, 2024) - Skye Bioscience, Inc. (OTCQB: SKYE) ('the Company'), a clinical stage
Breaking Biotech Funding News - Skye Bioscience (OTCQB: SKYE) Announces $50.25 Million Private Placement Equity Financing
Skye Bioscience, Inc. , a clinical stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid...
Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, has received clearance of its Investigational New Drug application with the U.S. Food and Drug...